Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy".

Autor: de Kam PJ; Allergy Therapeutics PLC, Worthing, UK., Zielen S; Children and Adolescents Deptartment, Allergology, Pulmonology & Cystic fibrosis, Goethe University, Frankfurt, Germany., Bernstein JA; Bernstein Clinical Research Center LLC, Cincinnati, Ohio, USA., Berger U; Department of Botany, University of Innsbruck, Innsbruck, Austria., Berger M; Department of Otorhinolaryngology, Wiener Gesundheitsverbund, Hospital Hietzing, Vienna, Austria., Cuevas M; Clinic and Polyclinic of Otorhinolaryngology, University Clinic Carl Gustav Carus, Dresden, Germany., Cypcar D; Allergy Partners of Western North Carolina, Asheville, North Carolina, USA., Fuhr-Horst A; ENT Research-Institut für klinische Studien, Essen, Germany., Greisner WA; Bluegrass Allergy Research, Lexington, Kentucky, USA., Jandl M; Hamburger Institut für Therapieforschung GmbH, Hamburg, Germany., Laßmann S; Studienzentrum Dr. Sabine Laßmann, Saalfeld, Germany., Worm M; Department of Dermatology and Allergy-Charite Campus Mitte, Universitätsmedizin Berlin, Berlin, Germany., Matz J; Chesapeake Clinical Research, Inc., White Marsh, Maryland, USA., Sher E; Allergy Partners of New Jersey, Ocean, New Jersey, USA., Smith C; Certified Research Associates, Cortland, New York, USA., Steven GC; Allergy Asthma & Sinus Center S.C., Greenfield, Wisconsin, USA., Mösges R; IMSB (Institute of Computational Biology and Medical Statistics), University at Cologne, Cologne, Germany.; ClinCompetence, Cologne, Germany., Shamji MH; Department of National Heart and Lung Institute, Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Imperial College London, London, UK.; Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, UK., DuBuske L; Division of Allergy and Immunology, Department of Internal Medicine, George Washington University Hospital, Washington, District of Columbia, USA., Borghese F; Allergy Therapeutics PLC, Worthing, UK., Oluwayi K; Allergy Therapeutics PLC, Worthing, UK., Zwingers T; Allergy Therapeutics PLC, Worthing, UK., Seybold M; Allergy Therapeutics PLC, Worthing, UK., Armfield O; Allergy Therapeutics PLC, Worthing, UK., Heath MD; Allergy Therapeutics PLC, Worthing, UK., Hewings SJ; Allergy Therapeutics PLC, Worthing, UK., Kramer MF; Allergy Therapeutics PLC, Worthing, UK., Skinner MA; Allergy Therapeutics PLC, Worthing, UK.

Publikováno v: Allergy [Allergy] 2024 Jun; Vol. 79 (6), pp. 1637-1638. Date of Electronic Publication: 2024 Mar 25.

Rhinitis 2020: A practice parameter update.

Autor: Dykewicz MS; Section of Allergy and Immunology, Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, School of Medicine, Saint Louis University, St Louis, Mo. Electronic address: mark.dykewicz@health.slu.edu., Wallace DV; Department of Medicine, Nova Southeastern Allopathic Medical School, Fort Lauderdale, Fla., Amrol DJ; Department of Internal Medicine, School of Medicine, University of South Carolina, Columbia, SC., Baroody FM; Department of Otolaryngology-Head and Neck Surgery, Pritzker School of Medicine, University of Chicago, Chicago, Ill., Bernstein JA; Allergy Section, Division of Immunology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio., Craig TJ; Departments of Medicine and Pediatrics, Penn State University, Hershey, Pa., Dinakar C; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, School of Medicine, Stanford University, Stanford, Calif., Ellis AK; Division of Allergy and Immunology, Department of Medicine, Queen's University, Kingston, Ontario, Canada., Finegold I; Division of Allergy and Immunology, Department of Medicine, Mount Sinai West, New York, NY., Golden DBK; Division of Allergy and Clinical Immunology, Department of Medicine, School of Medicine, John Hopkins University, Baltimore, Md., Greenhawt MJ; Section of Allergy and Immunology, Department of Pediatrics, Children's Hospital Colorado, School of Medicine, University of Colorado, Aurora, Colo., Hagan JB; Division of Allergic Diseases, Mayo Clinic, Rochester, Minn., Horner CC; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, School of Medicine, Washington University, St Louis, Mo., Khan DA; Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex., Lang DM; Department of Allergy and Clinical Immunology, Respiratory Institute, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio., Larenas-Linnemann DES; Center of Excellence in Asthma and Allergy, Hospital Medica Sur, Mexico City, Mexico., Lieberman JA; Division of Pulmonology Allergy and Immunology, Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, Tenn., Meltzer EO; Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, University of California, San Diego, Calif; Allergy and Asthma Medical Group and Research Center, San Diego, Calif., Oppenheimer JJ; Division of Pulmonary & Critical Care Medicine and Allergic & Immunologic Diseases, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey-Rutgers New Jersey Medical School, New Brunswick, NJ; Pulmonary and Allergy Associates, Morristown, NJ., Rank MA; Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic in Arizona, Scottsdale, Ariz., Shaker MS; Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Shaw JL; Prevea Health, Green Bay, Wis., Steven GC; Allergy, Asthma and Sinus Center, Greenfield, Wis., Stukus DR; Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, Ohio., Wang J; Division of Allergy and Immunology, Department of Pediatrics, The Elliot and Roslyn Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Dykewicz MS, Wallace DV, Dinakar C, Ellis AK, Golden DBK, Greenhawt MJ, Horner CC, Khan DA, Lang DM, Lieberman JA, Oppenheimer JJ, Rank MA, Shaker MS, Stukus DR, Wang J, Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, Finegold I, Hagan JB, Larenas-Linnemann DES, Meltzer EO, Shaw JL, Steven GC

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2020 Oct; Vol. 146 (4), pp. 721-767. Date of Electronic Publication: 2020 Jul 22.

EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.

Autor: Sher MR; Sher Allergy Specialist, Largo, FL, USA., Steven GC; Allergy, Asthma and Sinus Center, S.C., Greenfield, WI, USA., Romett JL; Colorado ENT and Allergy, Colorado Springs, CO, USA., Pien G; Summit Medical Group, Berkeley Heights, NJ, USA., LeBenger K; Summit Medical Group, Berkeley Heights, NJ, USA., Messina JC; OptiNose US Inc, Yardley, PA, USA., Carothers JL; OptiNose US Inc, Yardley, PA, USA., Mahmoud RA; OptiNose US Inc, Yardley, PA, USA., Djupesland PG; Optinose AS, Oslo, Norway.

Publikováno v: Rhinology [Rhinology] 2020 Feb 01; Vol. 58 (1), pp. 25-35.